机译:胰腺癌患者血清microRNA签名的潜在诊断价值
Copenhagen Univ Hosp Herlev &
Gentofte Hosp Dept Oncol Copenhagen Denmark;
Copenhagen Univ Hosp Rigshosp Dept Surg Gastroenterol &
Transplantat Copenhagen Denmark;
Danish Canc Soc Res Ctr Copenhagen Denmark;
Copenhagen Univ Hosp Rigshosp Dept Surg Gastroenterol &
Transplantat Copenhagen Denmark;
Danish Canc Soc Res Ctr Copenhagen Denmark;
Heidelberg Univ Dept Gen Visceral &
Transplant Surg Bergheimer Str 58 D-69115 Heidelberg Germany;
Copenhagen Univ Hosp Herlev &
Gentofte Hosp Dept Oncol Copenhagen Denmark;
Odense Univ Hosp Odense Denmark;
Copenhagen Univ Hosp Herlev &
Gentofte Hosp Dept Oncol Clin Biochem Copenhagen Denmark;
Heidelberg Univ Dept Gen Visceral &
Transplant Surg Bergheimer Str 58 D-69115 Heidelberg Germany;
Aalborg Univ Hosp Dept Clin Immunol Aalborg Denmark;
Hillerod Hosp Dept Oncol Hillerod Denmark;
Aalborg Univ Hosp Dept Oncol Aalborg Denmark;
Naestved Hosp Dept Oncol Naestved Denmark;
Danish Canc Soc Res Ctr Copenhagen Denmark;
pancreatic cancer; serum miRNA; early diagnosis;
机译:胰腺癌患者血清microRNA签名的潜在诊断价值
机译:血清microRNA-122 / 222水平升高是埃及慢性丙型肝炎但非肝癌患者的潜在诊断生物标志物
机译:胰腺癌患者血清ATX和LPA评估血清ATX和LPA
机译:在计算机上对microRNA进行调节,以从血清中识别出可能的胰腺癌生物标志物
机译:Ptf1a-Cre胰腺上皮内瘤变细胞中尿液,粪便和血清样品和胰腺肿瘤的代谢谱分析和HMGA1表达水平的评估; LSL-KrasG12D胰腺癌转基因小鼠模型
机译:胰腺癌患者血清ATX和LPA评估血清ATX和LPA
机译:血清microRNA标记物对胰腺癌的潜在诊断价值